These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
688 related articles for article (PubMed ID: 33189436)
1. PROTACs to address the challenges facing small molecule inhibitors. Martín-Acosta P; Xiao X Eur J Med Chem; 2021 Jan; 210():112993. PubMed ID: 33189436 [TBL] [Abstract][Full Text] [Related]
2. Small-molecule PROTACs: novel agents for cancer therapy. Wan Y; Yan C; Gao H; Liu T Future Med Chem; 2020 May; 12(10):915-938. PubMed ID: 32270707 [TBL] [Abstract][Full Text] [Related]
3. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead. Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718 [TBL] [Abstract][Full Text] [Related]
4. PROTACs technology for targeting non-oncoproteins: Advances and perspectives. Wang C; Zhang Y; Xing D; Zhang R Bioorg Chem; 2021 Sep; 114():105109. PubMed ID: 34175722 [TBL] [Abstract][Full Text] [Related]
5. Targeted protein degradation: A promise for undruggable proteins. Samarasinghe KTG; Crews CM Cell Chem Biol; 2021 Jul; 28(7):934-951. PubMed ID: 34004187 [TBL] [Abstract][Full Text] [Related]
6. PROTAC-DB: an online database of PROTACs. Weng G; Shen C; Cao D; Gao J; Dong X; He Q; Yang B; Li D; Wu J; Hou T Nucleic Acids Res; 2021 Jan; 49(D1):D1381-D1387. PubMed ID: 33010159 [TBL] [Abstract][Full Text] [Related]
7. Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges. Zeng S; Huang W; Zheng X; Liyan Cheng ; Zhang Z; Wang J; Shen Z Eur J Med Chem; 2021 Jan; 210():112981. PubMed ID: 33160761 [TBL] [Abstract][Full Text] [Related]
8. Developments of PROTACs technology in immune-related diseases. Wang C; Zhang Y; Deng J; Liang B; Xing D Eur J Med Chem; 2023 Mar; 249():115127. PubMed ID: 36724631 [TBL] [Abstract][Full Text] [Related]
9. PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics. Khan S; He Y; Zhang X; Yuan Y; Pu S; Kong Q; Zheng G; Zhou D Oncogene; 2020 Jun; 39(26):4909-4924. PubMed ID: 32475992 [TBL] [Abstract][Full Text] [Related]
10. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. An S; Fu L EBioMedicine; 2018 Oct; 36():553-562. PubMed ID: 30224312 [TBL] [Abstract][Full Text] [Related]
11. PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery. Gu S; Cui D; Chen X; Xiong X; Zhao Y Bioessays; 2018 Apr; 40(4):e1700247. PubMed ID: 29473971 [TBL] [Abstract][Full Text] [Related]
12. Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs. Gong L; Cui D; Xiong X; Zhao Y Adv Exp Med Biol; 2020; 1217():317-347. PubMed ID: 31898236 [TBL] [Abstract][Full Text] [Related]
14. VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives. Wang C; Zhang Y; Wang J; Xing D Eur J Med Chem; 2022 Jan; 227():113906. PubMed ID: 34656901 [TBL] [Abstract][Full Text] [Related]
15. Proteolysis-targeting chimeras mediate the degradation of bromodomain and extra-terminal domain proteins. Yang Y; Wu Z; Chen P; Zheng P; Zhang H; Zhou J Future Med Chem; 2020 Sep; 12(18):1669-1683. PubMed ID: 32893690 [TBL] [Abstract][Full Text] [Related]
16. Monitoring and deciphering protein degradation pathways inside cells. Daniels DL; Riching KM; Urh M Drug Discov Today Technol; 2019 Apr; 31():61-68. PubMed ID: 31200861 [TBL] [Abstract][Full Text] [Related]
17. Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy. Li X; Song Y J Hematol Oncol; 2020 May; 13(1):50. PubMed ID: 32404196 [TBL] [Abstract][Full Text] [Related]
18. PROTACs: New method to degrade transcription regulating proteins. Hu B; Zhou Y; Sun D; Yang Y; Liu Y; Li X; Li H; Chen L Eur J Med Chem; 2020 Dec; 207():112698. PubMed ID: 32858471 [TBL] [Abstract][Full Text] [Related]
19. Small-Molecule PROTACS: New Approaches to Protein Degradation. Toure M; Crews CM Angew Chem Int Ed Engl; 2016 Feb; 55(6):1966-73. PubMed ID: 26756721 [TBL] [Abstract][Full Text] [Related]
20. An overview of PROTACs: a promising drug discovery paradigm. Liu Z; Hu M; Yang Y; Du C; Zhou H; Liu C; Chen Y; Fan L; Ma H; Gong Y; Xie Y Mol Biomed; 2022 Dec; 3(1):46. PubMed ID: 36536188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]